Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:42:01 GMT 2025
by
admin
on
Mon Mar 31 21:42:01 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
699619YVTQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15352
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
C88315
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
Vorsetuzumab mafodotin
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
9610
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108672
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
YY-54
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
100000174939
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
699619YVTQ
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY | |||
|
1165741-01-4
Created by
admin on Mon Mar 31 21:42:01 GMT 2025 , Edited by admin on Mon Mar 31 21:42:01 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_145 | 1_201 |
| 1_262 | 1_322 |
| 1_368 | 1_426 |
| 2_22 | 2_96 |
| 2_145 | 2_201 |
| 2_262 | 2_322 |
| 2_368 | 2_426 |
| 3_23 | 3_92 |
| 3_138 | 3_198 |
| 4_23 | 4_92 |
| 4_138 | 4_198 |
| 1_221 | 3_218 |
| 2_221 | 4_218 |
| 1_227 | 2_227 |
| 1_230 | 2_230 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_298 |
| N | 2_298 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
|
CONJUGATE COMPONENT->CONJUGATE | |||
|
|
PARENT -> CONJUGATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_221] [1_227] [1_230] [2_221] [2_227] [2_230] [3_218] [4_218] | C |
Amount:
|
CYSTEINYL-MAFODOTIN | B4S8ET206U |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:ESTIMATED | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|